News About: R&D


Insurance price determination standards for new drugs under review.

The MOHW plans to make a Task Force for overall review of the new standards for insurance drug price determination that should be more reasonable and objective in consideration with characteristics of drugs and their ...

Whanin developed alcohol detoxicated drug for world 2nd time.

Whanin pharmaceutical company developed a manufacture of Acamprosate, an alcohol detoxicated drug under a joint research with Estech, a domestic venture company producing pharmaceutical bulk products after obtaining t...

Insurance pricing on new drugs specially privileged

The foreign multinational drug companies and local drug industries shared with common goals for the future insurance reimbursement price of new drugs to get some privileges in process of the government price determina...

Dongwha's DW166HC likely to be No. 2 new drugs in Korea.

SK pharmaceutical obtained the manufacturing licence of a platinum complex preparation as a new drug with passing through the clinical phase II studies only, which was exceptional for an anticancer drug while provisio...

Sunpla expected yearly to yeild 10 billion won of sales

As reported earlier SK Chemical and SK Pharmaceutical has developed an anti-cancer drug, a platinum complex, under the brand of Sunpla by about 8.1 billion won of investment during the past 10 years, which becomes the...

Domestic new drug No. 1, Sunpla inj. approved

The KFDA approved Sunpla inj., a platinum chelate complex anticancer drug, as the first new drug originated from Korea on July 13, which was developed by SK Pharmaceutical (President: Cho Min-ho) at 8.1 billion won of...

21 new drugs under clinical research.

Along with the first introduction of domestically developed new drug many interesting attentions are paid to the 21 candidates of new drugs in future, which are still under the clinical research stage and 2 ...

First new drug by domestic research soon to come out.

The introduction of the first NCE (new chemical entity) drug in Korea appears to speed up by SK pharmaceutical company, and for the same race Dongwha and Daewoong closely followed. Pacific pharmaceutical announced ...

First birth of domestic new drug seen this month

The clinical phase II-b study for Sunpla 50mg inj. (SKI 2053R), a platinum complex anti-cancer drug developed by SK Pharmaceutical Co. was successfully completed and now submitted to the Central Pharmaceutical Evaluat...

Choongwe: New quinolone compound Q-35 on clinical phase III

A new quinolone antibacterial drug, Q35 (Curoxin) will be performed its phase III clinical study accorded to the ICH standards at 13 hospitals including SNU hospital, starting from April, said Choongwe on April 22. ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.